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SOCS3 Negatively Regulates the gp130–STAT3
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Philip M. Murphy2 and Lothar Hennighausen1
Proliferation and differentiation of keratinocytes during wound healing are regulated by cytokines and
chemokines, which are secreted by resident and inflammatory cells and activate the transcription factor signal
transducer and activator of transcription (STAT)3. However, it is not clear to what extent STAT3 in keratinocytes is
activated by gp130-containing receptors. We addressed this question genetically by deleting the suppressor of
cytokine signaling (SOCS)3, a negative regulator of gp130-mediated STAT3 activation. Socs3 alleles flanked by
loxP sites were deleted in mice with either an MMTV-Cre or K5-Cre transgene. While both transgenes are active
in keratinocytes, the MMTV-Cre deletes floxed genes also in immune cells. Deletion of Socs3 using the MMTV-
Cre transgene resulted in aberrant STAT3 activation, impaired wound healing, prolonged secretion of
chemokines, a hyperproliferative epidermis, and neutrophil infiltration into wounds. Simultaneous deletion of
the Socs3 and gp130 genes restored normal wound healing. Moreover, deletion of Socs3 only in keratinocytes
caused impaired wound healing. These results demonstrate that wound healing is controlled in keratinocytes
by the gp130–SOCS3–STAT3 pathway and an imbalance of this pathway results in delayed wound healing.
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INTRODUCTION
Acute wound healing is a well-orchestrated biological
event composed of four distinct but overlapping phases:
hemostasis, inflammation, proliferation, and remodeling
(Diegelmann and Evans, 2004). Cytokines and chemokines
secreted by resident cells (keratinocytes, fibroblasts, and
endothelial cells) and inflammatory cells are involved in the
wound-healing process. Upon binding to their specific
receptors, these cytokines activate numerous signaling path-
ways, including those that utilize tyrosine kinases from the
Janus kinase family and transcription factors from the family
of signal transducer and activator of transcription (STAT)
proteins (Takeda and Akira, 2000; Murray, 2007). Epidermal
growth factor (EGF), transforming growth factor-a, heparin-
binding EGF-like factor, hepatocyte growth factor, and IL-6
are among the cytokines that activate STATs and control
the proliferation and differentiation necessary for wound
healing (Tarnawski and Jones, 1998; Yasukawa et al., 2003;
Tokumaru et al., 2005a, b). Basal keratinocytes express
STAT3, the common transcription factor activated by all
these cytokines (Sano et al., 1999, 2005; Quadros et al.,
2004; Tokumaru et al., 2005b).
Mouse genetics has revealed that some of these cytokines
and their receptors are required for the development of normal
skin structure and hair (Luetteke et al., 1993; Mann et al.,
1993; Sibilia and Wagner, 1995; Kim et al., 2001; Toyoda
et al., 2001; Lin et al., 2003; Arakawa et al., 2004; Shirakata
et al., 2005). Moreover, the specific ablation of STAT3 from
follicular and interfollicular keratinocytes resulted in impaired
wound healing (Sano et al., 1999). In vitro experiments
established a critical role for STAT3 in the migration but not
proliferation of keratinocytes (Sano et al., 1999).
Members of the family of suppressor of cytokine signaling
(SOCS) proteins are potent inhibitors of the Janus kinase–
STAT pathway, and activation of STAT3 through gp130-based
receptors is subject to negative regulation by SOCS3. SOCS3
has also been implicated in inflammatory responses of skin
tissue and its levels were elevated in atopic dermatitis
(Arakawa et al., 2004) and at sites of injury in mice (Goren
et al., 2006). Moreover, transfection of keratinocytes with
SOCS3 almost completely abolished HGF-induced STAT3
phosphorylation and migration (Tokumaru et al., 2005b).
Although several cytokines can activate STAT3 in keratino-
cytes in vitro, it is not clear to what extent each individual
pathway is functional in vivo. Moreover, the significance
of negative feedback loops in the activation of STAT3 in
keratinocytes remains to be determined.
Here we have used mouse genetics to address two distinct
questions. First, we explored the significance of STAT3
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signaling by cytokines, which activate gp130-containing
receptors in keratinocytes. Second, we explored the role of
SOCS3-mediated negative feedback loops in wound healing.
Toward these goals, we deleted the Socs3 gene in keratino-
cytes in vivo using Cre-mediated recombination, which resul-
ted in an aberrant activation of STAT3 and delayed wound
healing. Two lines of Cre-expressing transgenic mice were
used. The Mouse Mammary Tumor Virus (MMTV)-Cre mice
delete genes efficiently in keratinocytes and some immune cells
(Wagner et al., 1997, 2001), while the K5-Cre transgene
is specific to keratinocytes (Ramirez et al., 2004). To further
explore whether this STAT3-mediated delayed wound healing
was induced by gp130-containing receptors, we simultaneously
deleted the Socs3 and gp130 genes.
RESULTS
Socs3fl/fl; MMTV-Cre but not Socs3fl/fl; gp130fl/fl; MMTV-Cre mice
displayed impaired wound healing
Two distinct types of transgenic mice were generated:
mice that carried Socs3 alleles flanked by loxP sites and
the MMTV-Cre transgene (Socs3fl/fl; MMTV-Cre), and mice that
carried floxed Socs3 and gp130 alleles and the MMTV-Cre
transgene (Socs3fl/fl; gp130fl/fl; MMTV-Cre). Skin wounds were
introduced in these mice and in Socs3fl/fl control mice lacking
the Cre transgene. While wounds in the control group had
almost closed at day 14 after introduction of injury, the
wound areas in Socs3fl/fl; MMTV-Cre mice were only reduced by
60% (Figure 1a and b). Mice in which both Socs3 and gp130
genes had been deleted displayed wound closure similar to
that observed in controls (Figure 1a). These macroscopic
measurements reflect both the effect of wound contraction
and wound healing. The extent of collagen accumulation is
an indicator of the degree of wound healing. Compared
with control mice, there was less collagen accumulation, as
measured by hydroxyproline levels, at wound sites in
Socs3fl/fl; MMTV-Cre mice (Figure 1c), confirming a delayed
healing process. In contrast, collagen accumulation in
Socs3fl/fl; gp130fl/fl; MMTV-Cre mice (Figure 1c) was similar to
that seen in control mice (Figure 1c).
The absence of SOCS3 in keratinocyctes resulted in epithelial
hyperproliferation and increased P-STAT3
Hyperproliferative epidermis was observed in Socs3fl/fl; MMTV-Cre
mice 6 and 14 days after introducing the wound. In contrast,
little epidermal hyperproliferation was observed upon the
deletion of both the Socs3 and gp130 genes (Figure 2a).
To determine whether delayed wound healing was the result
of the loss of SOCS3 in keratinocytes or immune cells or both,
we deleted the Socs3 gene with a K5-Cre transgene. These
mice displayed impaired wound healing and hyperproliferation
of keratinocytes (Figure 2a). However, in contrast to
redness and swelling seen in Socs3fl/fl; MMTV-Cre mice, we
observed granulation tissue but no inflammatory symptoms
in Socs3fl/fl; K5-Cre mice. These data suggest that activation of
STAT3 through loss of SOCS3 in keratinocytes is the primary
cause of impaired wound healing and epidermal hyper-
proliferation.
Proliferating-cell nuclear antigen staining was used to
evaluate the extent of cell proliferation (Figure 2b). Deletion
of the Socs3 gene using either the MMTV-Cre or K5-Cre
transgene resulted in a higher rate of cell proliferation at
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Figure 1. Macroscopic changes at skin excisional wound sites. (a) Wound
sites were photographed at the indicated time. Day 0 (d0) pictures were
taken immediately after the injury. Representative results from 12 individual
mice in each group are shown. (b) Changes in percentage of wound
area at each time point compared with the original wound area.
(c) Hydroxyproline content, an index of collagen accumulation at the
wound site. Values represent mean±SEM. *Po0.05, **Po0.01 compared
with control mice.
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days 6 and 10 after introducing the wounds. The number of
proliferating-cell nuclear antigen-positive cells upon the loss
of the Socs3 and gp130 genes was similar to that observed
in controls.
Strong phosphorylated STAT3 staining was observed in
keratinocytes of Socs3fl/fl; MMTV-Cre mice at days 6 and
14 after wounding but not before introducing the lesions
(Figure 3a). Robust STAT3 phosphorylation was also observed
in Socs3fl/fl; K5-Cre mice. Phosphorylated STAT3 staining was
less intense in the absence of the Socs3 and gp130 genes
and similar to that observed in controls.
No significant STAT5 activation was detected in keratino-
cytes in any of the groups during the entire wound-healing
process (Figure 3b).
Loss of SOCS3 led to increased infiltration of neutrophils and
macrophages and elevated expression of chemokines
We next examined the consequences of loss of SOCS3
on leukocyte infiltration at the excisional wound sites.
Neutrophil infiltration in control mice peaked at day 1 and
remained at the same level for 3 days (Figure 4b and e). In
Socs3fl/fl; MMTV-Cre mice, a marked increase of neutrophil infil-
tration was observed on days 1 and 3 (Figure 4b and e).
An increased number of circulating neutrophils was only
observed in mice carrying the MMTV-Cre but not the K5-Cre
transgene, 3 days after wounding (Figure 4f). This demon-
strates that deletion of the Socs3 gene in keratinocytes resul-
ted in the accumulation of inflammatory cells in the wound
area. Socs3fl/fl; MMTV-Cre mice also displayed a significantly
increased infiltration of macrophages, which was already
apparent on day 1, reached maximum levels on day 6, and
remained high even at day 10 (Figure 4h and k). The number
of T cells did not change during the wound-healing process
(data not shown). Neutrophil (Figure 4c) and macrophage
(Figure 4i) infiltration was also elevated in Socs3fl/fl; K5-Cre
mice. In contrast, the combined loss of gp130 and SOCS3 did
not result in an increased neutrophil and macrophage
infiltration (Figure 4d and j).
Figure 2. Wound healing in the absence of SOCS3 and gp130. (a) Histopathological analyses of epidermis at skin wound sites of control, Socs3fl/fl; MMTV-Cre,
Socs3fl/fl; K5, and Socs3fl/fl; MMTV-Cre; gp130fl/fl; MMTV-Cre mice at days 6 (upper panel) and 14 (lower panel) after injury. Paraffin sections were stained with
hematoxylin and eosin. Rectangles indicate epidermis; * indicates hair follicles. (b) Immunohistochemical staining for proliferating-cell nuclear antigen (red)
and K5 (green) at the wound sites of control, Socs3fl/fl; MMTV-Cre, Socs3fl/fl; K5, and Socs3fl/fl; MMTV-Cre; gp130fl/fl; MMTV-Cre mice at days 6 (upper panel) and
10 (lower panel) after injury. # Indicates epidermis. Bar¼ 100mm.
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Levels of mRNA-encoding chemokines were deter-
mined by reverse transcriptase-PCR in skin tissue from
Socs3fl/fl; MMTV-Cre mice (Table 1). Macrophage-inflammatory
protein (MIP)-2 and keratinocyte-derived chemokine mRNA
levels increased significantly at day 1, remained elevated
until day 3, but decreased at day 6 of wound healing in
control mice. Macrophage-secreted MIP-1a was highly
expressed between days 1 and 6 of wound healing. How-
ever, mRNA expression levels of these chemokines were
markedly elevated in Socs3fl/fl; MMTV-Cre mice at all time
points and remained high throughout day 10 of wound
healing (Table 1).
Figure 3. Activation of STATs in wound healing. Immunohistochemical staining for phosphorylated STAT3 (a) and phosphorylated STAT5 (b) at wound sites in
control, Socs3fl/fl; MMTV-Cre, Socs3fl/fl; K5, and Socs3fl/fl; MMTV-Cre; gp130fl/fl; MMTV-Cre mice at days 0 (upper panel), 6 (middle panel), and 14 (lower panel).
Representative results from six mice in each group are shown. Red, P-STATs; green, E-cadherin. * Indicates hair follicles; # indicates epidermis. Bar¼100 mm.
For color figure see online version.
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Figure 4. Recruitment of immune cells. Immunohistochemical analyses of neutrophil (a–d) and macrophage (g–j) recruitment at skin excisional wound sites.
Anti-MPO on day 3 (a–d) or anti-F4/80 on day 6 (g–j) was used for immunohistochemical staining for neutrophils and macrophages, respectively. Hematoxylin
was used for counterstaining. Arrows indicate positively stained cells. Representative results from three independent experiments are shown. (e) MPO activity
at the wound site was determined to evaluate neutrophil accumulation. (f) Number of circulating neutrophils in peripheral blood in the different groups of mice.
(k) Number of macrophages per microscopic field. All values represent the mean±SEM (n¼ 6 mice). *Po0.05, compared with control mice. Bar¼ 50mm.
Table 1. RT-PCR results for chemokine RNA levels in wounded tissue
Day 1 Day 3 Day 6 Day 10
Control Socs3fl/fl; MMTV-Cre Control Socs3fl/fl; MMTV-Cre Control Socs3fl/fl; MMTV-Cre Control Socs3fl/fl; MMTV-Cre
MIP-2 1.5 2.5 1.8 2.6 0.1 3.5 0.1 1.2
KC 2.6 2.8 1.3 2.6 0.4 1.2 0.3 1.1
MIP-1a 1.7 3.2 1.8 3.5 1.8 3.0 0.4 2.5
KC, keratinocyte-derived chemokine; MIP, macrophage-inflammatory protein; RT-PCR, reverse transcriptase-PCR; SOCS, suppressor of cytokine signaling.
The numbers represent relative intensities of reverse transcriptase-PCR bands compared with the levels before wounding (day 0) in control mice, which were
set as 1. Data are the representative numbers of two to three individual experiments.
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DISCUSSION
Cytokines that activate the transcription factors STAT3 and
STAT5 control the growth and differentiation of keratinocytes
(Eckert and Welter, 1996; Hirano et al., 2000). A role for
STAT3 in skin remodeling and wound healing has been
established in mice from which the Stat3 gene had been
deleted specifically in the epidermis using Cre-mediated
recombination (Sano et al., 1999). As STAT3 can be activated
by gp130-containing receptors, such as the IL-6R, and by
receptor tyrosine kinases, such as the EGFR, it is not clear
to which extent these different receptor pathways contribute
to the STAT3-mediated wound healing. As demonstrated in
this study, deletion of SOCS3, the negative regulator of
gp130-mediated STAT3 signaling, in keratinocytes resulted in
elevated STAT3 phosphorylation and nuclear translocation,
epithelial hyperproliferation, and delayed wound healing.
This strongly supports the notion that cytokine signaling
through receptors containing the gp130 receptor subunit is
a principal cause of STAT3 activation. Evidence for this was
provided through the deletion of both the Socs3 and gp130
genes, which restored wound healing. Lastly, we suggest that
the presence of SOCS3 in keratinocytes is an essential part of
a gp130–SOCS3–STAT3 regulatory loop that provides a safe-
guard against excessive IL-6 signaling during the process of
wound healing.
Delayed wound healing in the absence of SOCS3 might
be due to hyperproliferating keratinocytes, which secrete
cytokines and chemokines to attract neutrophils and
macrophages. This would lead to a prolonged inflammatory
phase and delayed tissue remodeling. Mechanistically, loss of
SOCS3 led to excessive activation of STAT3 (Figure 5), which
probably triggered the observed epidermal hyperprolifera-
tion. In support of this, in vitro studies had shown that over-
expression of SOCS3 in HaCaT keratinocytes suppressed
cytokine-induced STAT3 phosphorylation and inhibited
serum-stimulated cell proliferation (Goren et al., 2006). As
the MMTV-Cre transgene is also active in immune cells,
delayed wound healing could be attributed in part to an
altered immune function. However, the deletion of the Socs3
gene specifically in keratinocytes, by means of a K5-Cre
transgene, also resulted in aberrant STAT3 activation, delayed
wound healing, and epithelial hyperproliferation. Thus, we
conclude that the negative regulation of STAT3 activation by
SOCS3 in keratinocytes is the primary mechanism to control
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Figure 5. Model depicting the consequences of absence of SOCS3 in wound healing. (a) Diagram of the IL-6–gp130–STAT3 signaling pathway and the
molecular consequences arising upon loss of Socs3. P, phosphorylated tyrosine residues; GAS, STAT-binding site. (b) Hyperproliferation of keratinocytes and
increased IL-6 and chemokines and elevated filtration of inflammatory cells at wound sites upon the deletion of SOCS3 in skin. KC, keratinocyte-derived
chemokine; MIP, macrophage-inflammatory protein.
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a balanced response to tissue injury. Although the loss of
SOCS3 in the two mouse models displayed a similar delay in
the wound repair process, there were also clear differences,
namely a more excessive inflammation in mice in which
the MMTV-Cre transgene had been used to delete the Socs3
gene. This can be attributed to the fact that these mice lack
SOCS3 in hematopoietic cells. Lastly, both loss of STAT3
(Sano et al., 1999) and hyperactivation of STAT3 result in
impaired wound healing. However, the underlying mecha-
nisms in these two models are different, as keratinocyte
migration is impaired upon loss of STAT3 and hyperprolifera-
tion is observed upon hyperactivation of STAT3.
The role of IL-6 and EGF-like ligands in cutaneous
repair has been studied extensively (Grose and Werner,
2003). Both EGF and transforming growth factor-a promote
re-epithelialization (Schultz et al., 1987), and analyses of
mice lacking the EGFR support the importance of this
signaling pathway (Tarnawski and Jones, 1998; Repertinger
et al., 2004). The importance of IL-6 in cutaneous wound
healing was demonstrated in mice lacking the IL-6 gene
(Gallucci et al., 2000, 2001; Lin et al., 2003). Both the EGF
and IL-6 pathways activate STAT3, which in itself, is required
for controlled wound healing. Our studies now demonstrate
that abolishing the negative regulatory loop of gp130
signaling in keratinocytes results in excessive STAT3 activa-
tion and epidermal hyperproliferation (summarized in
Figure 5). By the same token, blunting cytokine signaling
through gp130-based receptors by means of deleting
this subunit overtly restored the process of wound repair.
This suggests that non-gp130-mediated cytokine signaling
also controls wound healing and thus is part of a redundant
biological system. In summary, this study provides evidence
that SOCS3 is a critical negative regulator that balances
STAT3 activation in the process of wound healing, and
perturbation of this regulation delays wound healing.
MATERIALS AND METHODS
Mice
Mice carrying two Socs3 alleles flanked by loxP sites (Yasukawa
et al., 2003) were crossed with two different strains of mice
expressing either an MMTV-Cre or K5-Cre transgene. The MMTV-
Cre transgene is preferentially expressed in mammary and salivary
epithelium and the immune system (Wagner et al., 1997, 2001). In
contrast, the bovine keratin K5-Cre transgene is expressed specifi-
cally in keratinocytes (Ramirez et al., 2004). Socs3fl/fl mice lacking
transgenic Cre were used as controls. Socs3fl/fl; gp130fl/fl; MMTV-Cre
mice were generated by breeding Socs3fl/fl; MMTV-Cre mice with
gp130fl/fl mice (Zhao et al., 2004). The deletion efficiency of the
socs3 gene was determined by PCR analysis (Figure S1). Animals
were handled and housed in accordance with the guidelines of the
NIH Animal Care and Use Committee.
Antibodies and reagents
The following mAbs or polyclonal antibodies and recombinant
proteins were used in this study: rat anti-mouse F4/80 mAb
(eBioscience, San Diego, CA) and rabbit anti-myeloperoxidase
(MPO) polyclonal antibody (Lab Vision, Fremont, CA), rabbit anti-
STAT3, P-STAT3 and P-STAT5 (Cell Signaling Technologies,
Danvers, MA), proliferating-cell nuclear antigen (Dako, Carpinteria,
CA), rabbit anti-K5 (Covance, Princeton, NJ), mouse anti-E-cadherin
(BD Transduction Laboratories, Franklin Lakes, NJ), and b-catenin
(BD Transduction Laboratories). Alexafluor-conjugated secondary
antibodies (Molecular Probes, Carlsbad, CA) were used for visuali-
zation of bound primary antibodies using standard protocols.
Excisional wound preparation and macroscopic examination
Eight- to 12-week-old male mice were used for these experiments.
Mice were anesthetized with intraperitoneal administration of
Avertin (tribromoethanol, 0.3–0.6mg g1 weight) and full-thickness
skin wounds were made in the dorsal skin under sterile conditions as
described previously (Mori et al., 2002). Briefly, after shaving and
cleaning with 70% ethanol, excisional full-thickness skin wounds
were made in the dorsal skin by picking up a skin fold at the midline
and punching through two layers of skin with a sterile disposable
biopsy punch (diameter of 4mm; Miltex Inc., York, PA). The same
procedure was repeated on the same animals three times, generating
six wounds, with three wounds at each side. Each wound site
was digitally photographed at the indicated time intervals, and
wound areas were determined on photographs using PhotoShop
(version 6.0; Adobe Systems, San Jose, CA). Changes in wound areas
were expressed as the percentage of the initial wound areas. In some
experiments, wounds and their surrounding areas, including the scab
and epithelial margins, were cut with a sterile disposable biopsy
punch (diameter 8mm; Miltex Inc.) at the indicated time intervals for
further analysis.
MPO assay
MPO activity was measured to evaluate neutrophil recruitment (Mori
et al., 2002). Briefly, the excised wound samples were washed in
phosphate-buffered saline and homogenized in 1ml of 50mM
potassium phosphate buffer solution with 0.5% hexadecyl trimethyl
ammonium bromide (Sigma-Aldrich, St Louis, MO) and 5mM EDTA.
The samples were sonicated for 20 seconds, freeze–thawed three
times, and centrifuged at 12,000 r.p.m. at 4 1C. MPO activities in
the supernatants were assayed using the SUMILON peroxidase assay
kit (Sumitomo Bekuraito, Tokyo, Japan), according to the manufac-
turer’s instructions. The data were expressed as absorbance (unit)
per wound.
Measurement of hydroxyproline content in wound sites
After being dried for 16 hours at 120 1C, the contents of hydroxy-
proline, a major constituent of collagen in skin wound sites, were
measured as the index of collagen accumulation at the wound
site, as described previously (Ishida et al., 2004). Hydroxyproline
contents were calculated by comparison with standards and
expressed as the amount (mg) per wound.
Extraction of total RNAs and reverse transcriptase-PCR
Total RNAs were extracted from skin samples using TRIzol Reagent
(GIBCO, Carlsbad, CA) according to the manufacturer’s instructions.
A 5-mg weight of total RNA was reverse transcribed by using
Transcriptor First-Stand cDNA Synthesis kit (Roche, Nutley, NJ). The
resultant cDNAs were amplified with Taq polymerase (Invitrogen,
Carlsbad, CA) using specific sets of primers for MIP-2, keratinocyte-
derived chemokine, MIP-1a, IL-6 and glyceraldehyde-3-phosphate
dehydrogenase (Table 2). PCR amplification of each gene was
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conducted, with the optimal cycles consisting of 94 1C for 1minute,
optimal annealing temperature shown in Table 2 for 1minute, and
72 1C for 1minute, followed by incubation at 72 1C for 3minutes.
The amplified PCR products were fractionated on a 2% agarose gel
and visualized by ethidium bromide staining. The band intensities
were measured using AlphaImager software (Alpha Innotech, San
Leandro, CA) and the ratios to glyceraldehyde-3-phosphate dehydro-
genase were calculated.
Histology
Tissues were fixed in neutral buffered formalin (Fisher Scientific
Company, Kalamazoo, MI) at 4 1C overnight, dehydrated, and
embedded in paraffin. Tissue blocks were sectioned at 5 mm and
stained with hematoxylin and eosin. Sections from the middle of the
wounds were analyzed. Pictures were taken using an Olympus BX51
microscope (OPELCO, Tokyo, Japan) and a DXM1200 digital
camera (Nikon, Japan). For immunohistochemistry, tissue sections
were deparaffinized in xylene and rehydrated in decreasing alcohol
concentrations. Antigen unmasking was performed in a Decloaking
chamber (Biocare Medical, Concord, CA) using BORG Decloaker
solution (pH 9.5; Biocare Medical) at 125 1C, 18–24 psi for
5minutes, following 10minutes at 90 1C. Primary antibodies were
incubated overnight at 4 1C. Alexafluor-conjugated secondary
antibodies (Molecular Probes) were used at a dilution of 1:400 for
30minutes at room temperature. For avidin–biotin–peroxidase
complex staining, deparaffinized and dehydrated sections were
immersed in 0.3% H2O2 in methanol for 30minutes to eliminate
endogenous peroxidase activities. The sections were further incu-
bated with phosphate-buffered saline containing 1% rabbit normal
serum and 1% BSA to reduce nonspecific reactions. The sections
were then incubated with anti-F4/80 for murine macrophages, or
anti-MPO for neutrophils at a concentration of 1mgml1 at 4 1C,
overnight. Tissue sections were rinsed and subsequently incubated
with the secondary antibodies according to the manufacturer’s
protocol (Vector Laboratories, Burlingame, CA). The histological
methodology of sectioning has specific limitations. As the wounded
tissue heals, some wound areas contract and lose their round shapes.
Some sections might not have started from the middle of the wounds,
even though we used 8-mm punches to cut the wounds and their
surrounding areas, including the scab and epithelial margins.
Complete blood count for circulating neutrophils
Mice were bled from the mandibular vein before and 3 days after
wounding into 1.5ml microcentrifuge tubes through heparinized
capillary hematocrit tubes (Drummond Scientific Co., Broomall, PA).
Complete blood count was measured by HEMAVET multispecies
hematology system HV950FS (Drew Scientific Inc., Oxford, CT), as
per the manufacturer’s instructions.
All of the described studies were approved by the National
Institute of Diabetes and Digestive and Kidney Diseases of the
National Institutes of Health.
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SUPPLEMENTARY MATERIAL
Figure S1. PCR analysis of the floxed and recombined Socs3 alleles in skin
samples of Socs3fl/fl; MMTV-Cre, Socs3fl/fl; K5-Cre, and control mice.
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